INKT - Balance Sheet - MiNK Therapeutics, Inc.

Current Liabilities	6.96 M
Accounts Payable	2.73 M
Short-Term Debt	0
Other Current Liabilities	4.23 M
Non-Current Liabilities	18.3 M
Long-Term Debt	4.92 M
Other Non-Current Liabilities	13.4 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	4.6	3.4	19.6	38.9	2.7	0.3
Short Term Investments	0	0	0	0	0	0
Receivables	0	0	0	23 K	0	0
Inventory	0	0	0	1.76 K	1.0	87.7 K
Other Current Assets	0.2	0.2	0.8	0.7	1.4	0.6
Total Current Assets	5.0	3.6	20.4	39.6	4.1	0.9
PP&E	0	1.0	1.1	0.6	0.5	0.4
Intangible Assets	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0
Other Long Term Assets	732.9	0	0	0	0	0
Other Assets	(732.2)	0	0	0	0	0
Total Assets	5.7	4.6	21.5	40.2	4.6	1.3
LIABILITIES
Accounts Payable	2.7	3.9	5.8	3.0	3.1	2.5
Short Term Debt	0	0	0	0	0	0
Other Current Liabilities	4.2	7.5	6.9	13.5	10.8	4.8
Total Current Liabilities	7.0	11.4	12.7	16.5	14.2	7.4
Long Term Debt	4.9	0	0	0	43.8	26.8
Deferred Tax Income	0	0	0	0	0	0
Other Liabilities	13.4	11.2	9.2	0	0.4	3.4
Total Liabilities	25.3	22.6	21.9	16.5	58.4	37.6
EQUITY
Common Stock	40	346	339	335	242	241
Retained Earnings	(144 181.7)	(133.4)	(110.9)	(82.9)	(52.7)	(36.5)
Other Accumulative Comprehensive Income/Loss	(631.6)	(0.4)	(0.3)	(0.6)	(1.5)	(0.1)
Total Equity	(19.6)	(18.1)	(0.4)	23.8	(53.9)	(36.3)
Total Liabilities and Equity	5.7	4.6	21.5	40.2	4.6	1.3
SHARES OUTSTANDING
Common Shares Outstanding	37.7	34.4	33.7	33.5	33.1	33.1

Free